IRIS

The aim of this study was to investigate the impact of anti-HBc (HBcAb) positivity on the progression of liver fibrosis (Fibrosis-4 score >3.25) in the Italian cohort of HIV-infected individuals naïve to antiretroviral treatment (ICONA).

HBcAb Positivity Increases the Risk of Severe Hepatic Fibrosis Development in HIV/HCV-Positive Subjects From the ICONA Italian Cohort of HIV-Infected Patients

Segala Daniela
Membro del Collaboration Group
2021

Abstract

The aim of this study was to investigate the impact of anti-HBc (HBcAb) positivity on the progression of liver fibrosis (Fibrosis-4 score >3.25) in the Italian cohort of HIV-infected individuals naïve to antiretroviral treatment (ICONA).
2021
OPEN FORUM INFECTIOUS DISEASES
Malagnino, Vincenzo; Cerva, Carlotta; Cingolani, Antonella; Ceccherini-Silberstein, Francesca; Vergori, Alessandra; Cuomo, Gianluca; Perno, Carlo Federico; Puoti, Massimo; d'Arminio Monforte, Antonella; Cozzi-Lepri, Alessandro; Andreoni, Massimo; Sarmati, Loredana; Segala, Daniela
03.1 Articolo su rivista
File in questo prodotto:
File Dimensione Formato  
ofaa566.pdf

accesso aperto

Descrizione: Full text editoriale
Tipologia: Full text (versione editoriale)
Licenza: Creative commons
Dimensione 227.49 kB
Formato Adobe PDF
Visualizza/Apri
227.49 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11392/2433253
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 1
social impact